Dr Riccardo Privolizzi is a Senior Research Fellow in the Genetic Therapy Accelerator Centre at the UCL Queen Square Institute of Neurology. He's also an Honorary Research Fellow and Associate Lecturer in Gene Therapy at the UCL EGA Institute for Women's Health and GOS Institute of Child Health, and an ECR Board member of the British Society for Gene and Cell Therapy. Riccardo specialised in the characterisation of novel synthetic promoters and translational AAV gene therapy of a mouse model of infantile parkinsonism-dystonia. Riccardo has a keen interest in the identification and development of novel gene regulatory elements for selective targeting of specific cell types, and is passionate about teaching and science communication.